Good morning, and welcome to the IDEXX Laboratories Third Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay ...

IDEXX Laboratories is a leader in animal diagnostics, boasting strong recurring revenue and nearly 50% stock gains year-to-date. IDXX's innovation pipeline, robust cash position, and global reach ...

Idexx Laboratories benefits from operating in the resilient pet healthcare industry. The company's razor-and-blade business model adds a degree of stability for investors. Idexx is soon to expand into ...

Seilern sold 70,900 shares of IDEXX Laboratories; estimated transaction value of approximately $43.03 million. The sale represents a 3.11% change relative to the fund’s 13F AUM. Post-trade holding: ...

Idexx Laboratories Inc., based in Westbrook, Maine, has completed the purchase of Vet Med Lab, a provider of veterinary reference laboratory services in the European market, for approximately $31 ...

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a wide moat. It is well-positioned to benefit from two key trends. First, pet ownership ...

IDEXX Laboratories, Inc. (“Labs”) has long been involved in developing, manufacturing, and selling veterinary diagnostic tests, products, and services. Labs invented heartworm tests in the 1980s and ...